Rezvilutamide
Drug timelines are a Plus or Pro feature.
8 regulatory and trial events tracked for Rezvilutamide, covering 2023-07-21 to 2026-03-24. Get the full timeline:
Most recent: Clinical Trial Update: Rezvilutamide With Radical Prostatectomy and Metastasis-Directed Therapy in Oligometastatic Prostate Cancer [Phase 2]